Cellular Therapy Standards Committee

Purpose:

Edit and draft standards and guidance for Cellular Therapy Product collection, processing and administration for recommendation to the FACT and JACIE Board of Directors for approval and implementation.

Function:

  • Subcommittee chairs and vice-chairs meet initially to plan the overall structure of the new edition of standards
  • Acquire approval of FACT and JACIE Boards of Directors if major changes from previous editions are recommended.
  • Subcommittees meet weekly or bi-weekly by teleconference during the editing and drafting phase (18 months prior to release of new edition).
  • Subcommittee chairs and co-chairs meet monthly by teleconference during the editing and drafting phase to facilitate continuity of structure and language throughout the standards.
  • Submit final draft to the FACT office for review and editing.
  • Submit final draft to the FACT and JACIE Boards of Directors for approval.
  • Distribute draft to ISCT, ASBMT, JACIE, and EBMT membership for comment.
  • FACT, and JACIE Board of Directors evaluate membership comments and approve or disapprove as appropriate.
  • Publication and distribution of revised edition.

Members:

Cellular Therapy Standards Committee Leadership

Subcommittees:

Cellular Therapy Clinical Program Standards

Cellular Therapy Collection Facility Standards

Cellular Therapy Processing Facility Standards

Ask FACT

FAQ

Ask a Peer

As a Matter of FACT

FACT was formally known as “FAHCT” (The Foundation for the Accreditation of Hematopoietic Cellular Therapy) until it expanded operations into other cellular therapies beyond hematopoietic cells.

Accreditation Success Story

Hoxworth Blood Center Apheresis Collection Facility and its Cellular Therapies Division have been accredited by FACT since 2003. The program values their FACT accreditation and the impact it has had on their program’s continuous quality improvement objectives. Read more